PEP
51
7
PNC
75
3
XOM
45
3
TSCO
72
2
HCA
66
-9
DGX
53
-4
WYNN
48
2
VIX
30
-2
FFIV
64
-2
AN
60
2
MCHP
67
2
HPQ
55
2
HST
47
2
VFC
50
2
UHS
64
-4
CMG
60
-9
GOOG
55
2
AIG
51
-8
DRI
67
10
DAL
69
3
PEP
51
7
PNC
75
3
XOM
45
3
TSCO
72
2
HCA
66
-9
DGX
53
-4
WYNN
48
2
VIX
30
-2
FFIV
64
-2
AN
60
2
MCHP
67
2
HPQ
55
2
HST
47
2
VFC
50
2
UHS
64
-4
CMG
60
-9
GOOG
55
2
AIG
51
-8
DRI
67
10
DAL
69
3
Financhill
Back

Cytokinetics Stock Predictions

Built for Lazy Summer Markets

Get instant access today.
Sell
31

CYTK
Cytokinetics

Last Price:
$34.64
Seasonality Move:
5.89%

7 Day Trial

ALL ACCESS PASS

$ 7

One Tool. Personalized Setups.

Try it here.

Cytokinetics Stock Forecast

  • Over the next 52 weeks, Cytokinetics has on average historically risen by 12.8% based on the past 21 years of stock performance.
  • Cytokinetics has risen higher in 9 of those 21 years over the subsequent 52-week period, corresponding to a historical accuracy of 42.86%
  • Is Cytokinetics Stock Undervalued?
    The current Cytokinetics [CYTK] share price is $34.36. The Score for CYTK is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
  • CYTK is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Cytokinetics Stock Go Up Next Year?

  • Over the next 52 weeks, Cytokinetics has on average historically risen by 12.8% based on the past 21 years of stock performance.

Cytokinetics Stock Rating

Sell
31
Cytokinetics (CYTK) is a Sell

Is Cytokinetics overpriced?

  • Cytokinetics has risen higher in 9 of those 21 years over the subsequent 52-week period, corresponding to a historical accuracy of 42.86%

Cytokinetics Stock Price History

Is CYTK stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CYTK is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
cytokinetics.com

52-Week Data

52-Week High:
61.38
52-Week Low:
29.31

Prediction Charts

Market Cap:
4.1B
Price in USD:
34.36
Volume:
1.3M
Beta:
1.40

Technical Analysis

SMA50:
33.79
SMA100:
38.33
SMA200:
44.86
52-Wk Change:
-37.35%

Stock Predictions

  • Is Cytokinetics stock public?
    Yes, Cytokinetics is a publicly traded company.
  • What is the Cytokinetics stock quote today?
    The Cytokinetics stock price is 34.36 USD today.
  • How to buy Cytokinetics stock online?
    You can buy Cytokinetics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jun-12 32.72 33.20 33.97 32.60
Jun-13 32.64 34.38 34.41 32.64
Jun-16 34.72 33.78 34.72 32.84
Jun-17 33.31 32.54 33.67 32.47
Jun-18 32.58 32.73 33.18 32.02
Jun-20 32.81 32.43 33.17 32.07
Jun-23 32.32 32.64 32.78 31.99
Jun-24 32.99 33.40 34.08 32.22
Jun-25 33.21 33.11 33.26 32.63
Jun-26 33.24 33.91 33.97 32.66
Jun-27 34.03 33.16 34.34 32.89
Jun-30 33.05 33.04 33.53 32.70
Jul-1 32.92 33.64 34.38 32.66
Jul-2 33.60 34.36 35.09 33.51

Cytokinetics Earnings

Cytokinetics Earnings Report: Per Share Cytokinetics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Cytokinetics Forecast Revenue Growth

Cytokinetics Stock Analysis: Historical quarterly revenues per share for Cytokinetics and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.15 per share, an increase next quarter of $0.59 per share, a decrease this year of $0.32 per share, and an increase next year of $0.32 per share.

* Cytokinetics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.